103 related articles for article (PubMed ID: 6146333)
41. Chronic β-adrenoceptor antagonists upregulate the rat alveolar macrophage adrenergic system through the β1-subtype.
Guo YP; Liu Y; Li JB; Huang Y; Qi HP; Xie J; Cui XG; Yue ZY; Li WZ
Cell Physiol Biochem; 2011; 28(2):315-22. PubMed ID: 21865739
[TBL] [Abstract][Full Text] [Related]
42. Metabolic actions of a single atenolol and metoprolol dose.
Kulcsár-Gergely J; Pósán E; Kulcsár A
Arzneimittelforschung; 1994 Nov; 44(11):1183-5. PubMed ID: 7848328
[TBL] [Abstract][Full Text] [Related]
43. Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro.
Hallengren B; Forsgren A; Melander A
Br J Clin Pharmacol; 1982 Apr; 13(4):543-6. PubMed ID: 6121578
[TBL] [Abstract][Full Text] [Related]
44. Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
Suemaru K; Gomita Y; Furuno K; Araki Y
Pharmacol Biochem Behav; 1993 Sep; 46(1):131-3. PubMed ID: 7902979
[TBL] [Abstract][Full Text] [Related]
45. Beta-adrenoceptor antagonists and human sperm motility.
Curtis-Prior PB; Gadd AL
J Pharm Pharmacol; 1990 Mar; 42(3):220-2. PubMed ID: 1974626
[TBL] [Abstract][Full Text] [Related]
46. [Stereoselectivity in N-dealkylation of disopyramide enantiomers in mouse hepatic microsomes].
Kiriyama A; Morita K; Shimakawa H; Yokoyama T
Yakugaku Zasshi; 1992 Jan; 112(1):61-4. PubMed ID: 1578345
[TBL] [Abstract][Full Text] [Related]
47. The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin.
Bax ND; Lennard MS; Tucker GT; Woods HF; Porter NR; Malia RG; Preston FE
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):85S. PubMed ID: 6146343
[No Abstract] [Full Text] [Related]
48. A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol.
Schürmann W; Turner P
J Pharm Pharmacol; 1978 Mar; 30(3):137-47. PubMed ID: 24685
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.
Deacon CS; Lennard MS; Bax ND; Woods HF; Tucker GT
Br J Clin Pharmacol; 1981 Sep; 12(3):429-31. PubMed ID: 6117306
[No Abstract] [Full Text] [Related]
50. Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.
Hong CY; Turner P
Br J Clin Pharmacol; 1982 Aug; 14(2):269-72. PubMed ID: 6125206
[TBL] [Abstract][Full Text] [Related]
51. Brain levels and acute antihypertensive activity of beta-blockers.
van Zwieten PA; Timmermans PB
Eur J Clin Pharmacol; 1985; 28 Suppl():13-9. PubMed ID: 2865143
[TBL] [Abstract][Full Text] [Related]
52. Absorption of beta-adrenoceptor antagonists to Amberlite resin.
Heath A; Gabrielsson M; Redgårdh CG
Br J Clin Pharmacol; 1983 Apr; 15(4):490-2. PubMed ID: 6133547
[TBL] [Abstract][Full Text] [Related]
53. Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers.
Drayer DE
Pharmacotherapy; 1987; 7(4):87-91. PubMed ID: 2891122
[TBL] [Abstract][Full Text] [Related]
54. Partition and distribution coefficients of aryloxypropanolamine beta-adrenoceptor antagonists.
Recanatini M
J Pharm Pharmacol; 1992 Jan; 44(1):68-70. PubMed ID: 1350635
[TBL] [Abstract][Full Text] [Related]
55. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.
Park BK
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):3S-10S. PubMed ID: 6146338
[TBL] [Abstract][Full Text] [Related]
56. Demethylation studies. VII. A unique effect of the N-cyclopropyl group in a new series of inhibitors of oxidative microsomal demethylation.
McMahon RE; Culp HW; Mills J
J Med Chem; 1970 Sep; 13(5):986-7. PubMed ID: 5458400
[No Abstract] [Full Text] [Related]
57. Effects of ethanol on hepatic microsomal drug-metabolizing enzymes in the rat.
Liu SJ; Ramsey RK; Fallon HJ
Biochem Pharmacol; 1975 Feb; 24(3):369-78. PubMed ID: 1125043
[No Abstract] [Full Text] [Related]
58. Hepatic microsomal propranolol metabolism in aging male and female rats.
Fujita S; Ishida R; Obara S; Kitani K; Suzuki T
J Pharm Sci; 1991 Feb; 80(2):199-200. PubMed ID: 2051331
[No Abstract] [Full Text] [Related]
59. The screening of selected microorganisms for use as models of mammalian drug metabolism.
Griffiths DA; Best DJ; Jezequel SG
Appl Microbiol Biotechnol; 1991 Jun; 35(3):373-81. PubMed ID: 1367317
[TBL] [Abstract][Full Text] [Related]
60. Endogenous uremic substances are not involved in the reduced hepatic extraction of metoprolol in bilateral ureter-ligated rats.
Taguchi M; Urai M; Taira S; Tanabe H; Hashimoto Y
Drug Metab Pharmacokinet; 2006 Apr; 21(2):156-64. PubMed ID: 16702736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
